Search Result "KRAS wild type"


Cetuximab/Irinotecan-Chemotherapy in KRAS Wild-type Pretreated Metastatic Colorectal Cancer: A Pooled Analysis and Review of Literature.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 101-109
Author(s): Sandro Barni,Mara Ghilardi,Karen Borgonovo,Mary Cabiddu,Alberto Zaniboni,Fausto Petrelli

Review Article

Targeting Mutant KRAS for Anticancer Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2098-2113
Author(s): Fengqian Chen,Martin P. Alphonse,Yan Liu,Qi Liu

Review Article

KRAS: A Promising Therapeutic Target for Cancer Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2081-2097
Author(s): Hai-Zhou Wu,Jia-Qi Xiao,Song-Shu Xiao,Yan Cheng

Cetuximab Inhibits Gastric Cancer Growth in vivo, Independent of KRAS Status

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 2 Year: 2014 Page: 217-224
Author(s): Min Shi,Hailong Shi,Jun Ji,Qu Cai,Xuehua Chen,Yingyan Yu,Bingya Liu,Zhenggang Zhu,Jun Zhang

Review Article

Overview of Current Immunotherapies Targeting Mutated KRAS Cancers

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2158-2175
Author(s): Winfrey Pui Yee Hoo,Pui Yan Siak,Lionel L.A. In

Review Article

Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2128-2142
Author(s): Hao He,Chang Xu,Zhao Cheng,Xiaoying Qian,Lei Zheng

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 163-171
Author(s): Tomoya Yokota

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli

Research Article

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

Journal: Current Cancer Drug Targets
Volume: 17 Issue: 1 Year: 2017 Page: 89-97
Author(s): Chenfei Zhou,Liangjun Zhu,Jun Ji,Fangmi Ding,Chao Wang,Qu Cai,Yingyan Yu,Zhenggang Zhu,Jun Zhang

Review Article

Moving Towards Dawn: KRas Signaling and Treatment in PancreaticDuctal Adenocarcinoma

Journal: Current Molecular Pharmacology
Volume: 15 Issue: 7 Year: 2022 Page: 904-928
Author(s):

Previous   Next

Go To   Results 1 - 1 of 745

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy